Renaissance Technologies’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,872,893
| Closed | -$27.1M | – | 3330 |
|
|
2026
Q1 | $27.1M | Buy |
1,872,893
+661,200
| +55% | +$9.48M | 0.04% | 540 |
|
|
2025
Q4 | $17.3M | Sell |
1,211,693
-731,478
| -38% | -$7.19M | 0.03% | 669 |
|
|
2025
Q3 | $15.3M | Sell |
1,943,171
-70,422
| -3% | -$501K | 0.02% | 866 |
|
|
2025
Q2 | $11.5M | Buy |
2,013,593
+451,600
| +29% | +$2.91M | 0.02% | 982 |
|
|
2025
Q1 | $12.7M | Sell |
1,561,993
-546,623
| -26% | -$5.06M | 0.02% | 877 |
|
|
2024
Q4 | $19.9M | Buy |
2,108,616
+1,339,316
| +174% | +$13.9M | 0.03% | 672 |
|
|
2024
Q3 | $8.22M | Buy |
769,300
+137,276
| +22% | +$1.5M | 0.01% | 1144 |
|
|
2024
Q2 | $6.27M | Sell |
632,024
-324,176
| -34% | -$3.33M | 0.01% | 1172 |
|
|
2024
Q1 | $11.3M | Buy |
956,200
+878,800
| +1,135% | +$11.2M | 0.02% | 929 |
|
|
2023
Q4 | $1.1M | Sell |
77,400
-71,000
| -48% | -$806K | ﹤0.01% | 2348 |
|
|
2023
Q3 | $1.8M | Buy |
+148,400
| New | +$1.91M | ﹤0.01% | 1930 |
|
|
2023
Q2 | – | Sell |
-389,000
| Closed | -$4.31M | – | 4040 |
|
|
2023
Q1 | $4.31M | Buy |
+389,000
| New | +$4.79M | 0.01% | 1561 |
|
|
2022
Q4 | – | Sell |
-284,800
| Closed | -$2.97M | – | 4196 |
|
|
2022
Q3 | $2.97M | Buy |
+284,800
| New | +$3.17M | ﹤0.01% | 1764 |
|
|
2020
Q1 | – | Sell |
-129,854
| Closed | -$1.26M | – | 3545 |
|
|
2019
Q4 | $1.26M | Sell |
129,854
-1,340,946
| -91% | -$12.3M | ﹤0.01% | 2524 |
|
|
2019
Q3 | $11.8M | Buy |
1,470,800
+1,217,000
| +480% | +$13.2M | 0.01% | 1284 |
|
|
2019
Q2 | $3.17M | Buy |
+253,800
| New | +$3.22M | ﹤0.01% | 2092 |
|
|
2016
Q4 | – | Sell |
-196,400
| Closed | -$1.45M | – | 3311 |
|
|
2016
Q3 | $1.45M | Buy |
+196,400
| New | +$1.33M | ﹤0.01% | 2385 |
|
|
2015
Q1 | – | Sell |
-508,700
| Closed | -$4.23M | – | 3225 |
|
|
2014
Q4 | $4.23M | Buy |
508,700
+378,300
| +290% | +$2.6M | 0.01% | 1369 |
|
|
2014
Q3 | $776K | Buy |
+130,400
| New | +$683K | ﹤0.01% | 2145 |
|
|
2014
Q2 | – | Sell |
-121,000
| Closed | -$250K | – | 2839 |
|
|
2014
Q1 | $250K | Sell |
121,000
-278,401
| -70% | -$696K | ﹤0.01% | 2565 |
|
|
2013
Q4 | $939K | Buy |
399,401
+96,801
| +32% | +$212K | ﹤0.01% | 2105 |
|
|
2013
Q3 | $702K | Buy |
302,600
+128,956
| +74% | +$324K | ﹤0.01% | 2173 |
|
|
2013
Q2 | $405K | Buy |
+173,644
| New | +$534K | ﹤0.01% | 2310 |
|
Other funds holding FOLD
Renaissance Technologies's FOLD Position: Q2 2026 in Review
Renaissance Technologies sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 1,872,893 shares — an estimated $27.1M sold.
Renaissance Technologies first reported a position in FOLD in Q2 2013 and held it in 23 quarters. The position peaked at $27.1M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.
- Renaissance Technologies reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
- Renaissance Technologies sold 1,872,893 Amicus Therapeutics shares in Q2 2026, an estimated $27.1M.
- Renaissance Technologies first reported a position in Amicus Therapeutics in Q2 2013 and held it in 23 quarters.
- Renaissance Technologies's Amicus Therapeutics position peaked at $27.1M in Q1 2026.
- 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.